Related Experiment Video

Updated: Aug 25, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Cyclosporine nephrotoxicity

J M Grinyó1, J M Cruzado

  • 1Nephrology Department, Hospital Universitari de Bellvitge, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. jgrinyo@csub.scs.es

Transplantation Proceedings
|March 26, 2004
PubMed

Insights

Cyclosporine, an immunosuppressant, aids organ transplant survival by inhibiting calcineurin. However, its long-term use causes kidney damage, necessitating new strategies for immunosuppression.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Cyclosporine is a prodrug immunosuppressant targeting calcineurin, a phosphatase crucial for T cell activation and cytokine regulation.
  • Calcineurin inhibition by cyclosporine leads to immunosuppression and nephrotoxicity, affecting organs like the kidney.
  • Cyclosporine significantly improved renal allograft survival by reducing acute rejection episodes.

Purpose of the Study:

  • To review the long-term impact of cyclosporine on renal allografts and explore emerging immunosuppression concepts.
  • To address the undefined targets for maintenance immunosuppression and the unknown extent of chronic cyclosporine nephrotoxicity.
  • To discuss the role of new technologies like DNA microarrays in differentiating drug toxicity from other causes of graft deterioration.

Main Methods:

  • Literature review and analysis of historical data on renal transplantation outcomes.
  • Discussion of the mechanism of action of cyclosporine and its effects on calcineurin.
  • Exploration of emerging technologies and future directions in immunosuppression.

Main Results:

  • Cyclosporine has been instrumental in improving graft survival in renal transplantation.
  • Chronic cyclosporine nephrotoxicity remains a significant concern with unclear magnitude due to diagnostic limitations.
  • Chronic renal failure is a recognized adverse event post-transplantation of non-renal organs, associated with increased mortality.

Conclusions:

  • While cyclosporine has benefited organ transplantation, its long-term nephrotoxicity requires further investigation.
  • New technologies like DNA microarrays may help distinguish drug toxicity from other causes of graft damage.
  • Exploring calcineurin-free immunosuppression strategies is warranted for future advancements in transplantation.

More Related Videos

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...